404
Page Not Found
The page you're looking for doesn't exist or has been moved.
The page you're looking for doesn't exist or has been moved.
Trimi Medical Review Team
Clinical review workflow for GLP-1 safety, dosing, and access content
Team-based medical review process documented in Trimi's Medical Review Policy
Last reviewed: November 26, 2025
Medical Writers & Healthcare Professionals
Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.
Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.
Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.
Most patients lose 3-7 pounds in the first month on tirzepatide. See clinical data, what changes to expect, side effects, and how month 1 compares to semaglutide.
Review 1-year tirzepatide results from SURMOUNT clinical trials including weight loss outcomes, metabolic improvements, side effect profiles, and what happens after year one.
Women in SURMOUNT-1 lost an average of 22.4% body weight at 72 weeks. See the realistic timeline, dose-response data, and what factors predict the best results.
At 3 months on tirzepatide, average weight loss is 7-10% of body weight. See SURMOUNT trial data, dose-dependent results, and comparison with semaglutide at the same timepoint.